ZALICUS PHARMACEUTICALS
Zalicus Pharmaceuticals operates as a biopharmaceutical company which develops chronic pain drugs.
ZALICUS PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.zalicus.com
Total Employee:
11+
Status:
Active
Contact:
+1-604-909-2530
Similar Organizations
Aerogen, Inc.
Aerogen, Inc. operates as a specialty pharmaceutical company that develops, manufactures, and commercializes pulmonary.
AlcaSynn Pharmaceuticals GmbH
Drug development company focusing on small molecules of the morphinan group. In 2006 AlcaSynn was acquired by Sanochemia Pharmazeutika
Altum Pharmaceuticals
Altum Pharmaceuticals operates as a biopharmaceutical company.
Avenzoar Pharmaceuticals
Avenzoar Pharmaceuticals is a pharmaceutical company developing cancer drugs.
Maxim Pharmaceuticals
Maxim Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative cancer therapeutics.
P2D Bioscience
This company is a specialty pharmaceutical company focused on developing innovative drugs.
Patrin Pharma
Patrin Pharma is a pharmaceutical company that develops a portfolio of niche generic products.
Rivus Pharmaceuticals
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
Wex Pharmacetuicals
WEX Pharmaceuticals Inc. is a biopharmaceutical company that developing a late-stage non-opioid analgesic.
Official Site Inspections
http://www.zalicus.com
- Host name: ec2-13-56-33-8.us-west-1.compute.amazonaws.com
- IP address: 13.56.33.8
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Zalicus Pharmaceuticals"
Zalicus Company Profile 2024: Valuation, Investors, โฆ
Information on acquisition, funding, cap tables, investors, and executives for Zalicus. Use the PitchBook Platform to explore the full profile.See details»
Zalicus Pharmaceuticals - Crunchbase Company Profile โฆ
Zalicus Pharmaceuticals operates as a biopharmaceutical company which develops chronic pain drugs.See details»
Zalicus - Products, Competitors, Financials, Employees, โฆ
Zalicus, formerly CombinatoRx, is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs, designed to attack disease โฆSee details»
Zalicus Inc. - VentureRadar
"Zalicus Inc., is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immune-inflammatory diseases. The company applies its โฆSee details»
Zalicus, Inc. - Drug pipelines, Patents, Clinical trials - Patsnap
Explore Zalicus, Inc. with its drug pipeline, therapeutic area, technology platform, 22 clinical trials, 13 news, and 35 literature, Disease Domain:Endocrinology and ...See details»
Zalicus - Contacts, Employees, Board Members, Advisors & Alumni
Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.See details»
Organization | Zalicus - Purdue University
Acquisitions Trial Sponsor Other Trial Involvement2012See details»
CombinatoRx Changes Company Name to Zalicus Inc. - Fierce โฆ
Sep 9, 2010 Zalicus utilizes proprietary drug design and electrophysiological screening processes to create drug candidates with improved levels of specificity, enabling the discovery โฆSee details»
Zalicus | Scientist.com
Zalicus is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. Zalicus applies its expertise in the discovery and development of selective โฆSee details»
Zalicus - Funding, Financials, Valuation & Investors
Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.See details»
U.S. arm of Sun Pharma's Taro buys Zalicus ... - Fierce Pharma
Oct 14, 2015 The acquisition of Canada's Zalicus Pharmaceuticals by a U.S. subsidiary of India's largest drugmaker, Sun Pharmaceuticals, is being seen as a move to strengthen its โฆSee details»
Epirus Acquiring Zalicus, Adding Pain Drugs to Product Lineup
Apr 16, 2014 Epirus Biopharmaceuticals said today it will acquire Zalicus, in a deal that adds a pipeline of new product candidates and drug discovery platforms to the acquiring companyโs โฆSee details»
Zalicus Inc. | Insights
Latest on Zalicus Inc. Already A Biomedtracker Subscriber?You have access to the full company record through your subscription.See details»
Zalicus Pharmaceuticals - Crunchbase
Zalicus Pharmaceuticals operates as a biopharmaceutical company which develops chronic pain drugs.See details»
Zalicus, Inc.
ไบ่งฃZalicus, Inc. (Zalicus, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็22้กนไธดๅบ่ฏ้ช, 15็ฏๆฐ้ปๅ35็ฏๆ็ฎ๏ผ็พ็ ้ขๅ:ๅ ๅๆณไธไปฃ่ฐข็พ็ ๏ผ็ฅ็ป็ณป็ป็พ็ ๏ผๆๆ๏ผๅ ็ซ็ณป็ป็พ็ ๏ผ โฆSee details»
Zalicus Inc. - VentureRadar
Zalicus Inc., is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immune-inflammatory diseases. The company applies its โฆSee details»
Zalicus Reports Results from Phase 2 Clinical Trials of Z160 in โฆ
Nov 11, 2013 Based on these results, Zalicus is discontinuing the Z160 program and plans to focus efforts on Z944, its novel oral T-type calcium channel modulator in development for the โฆSee details»
Zalicus - Crunchbase
Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.See details»
Zalicus Pharmaceuticals acquired by Taro Pharmaceuticals
Oct 14, 2015 Taro Pharmaceuticals Taro Pharmaceuticals is a research-based pharmaceutical company that develops over-the-counter pharmaceutical products.See details»